A Phase 1b Study of Vadastuximab Talirine (33A) in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
Publication
, Conference
Walter, R; Erba, H; Ravandi, F
Published in: ANNALS OF HEMATOLOGY
February 1, 2017
Duke Scholars
Published In
ANNALS OF HEMATOLOGY
EISSN
1432-0584
ISSN
0939-5555
Publication Date
February 1, 2017
Volume
96
Start / End Page
S69 / S69
Publisher
SPRINGER
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Walter, R., Erba, H., & Ravandi, F. (2017). A Phase 1b Study of Vadastuximab Talirine (33A) in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML). In ANNALS OF HEMATOLOGY (Vol. 96, pp. S69–S69). SPRINGER.
Walter, R., H. Erba, and F. Ravandi. “A Phase 1b Study of Vadastuximab Talirine (33A) in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML).” In ANNALS OF HEMATOLOGY, 96:S69–S69. SPRINGER, 2017.
Walter R, Erba H, Ravandi F. A Phase 1b Study of Vadastuximab Talirine (33A) in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML). In: ANNALS OF HEMATOLOGY. SPRINGER; 2017. p. S69–S69.
Walter, R., et al. “A Phase 1b Study of Vadastuximab Talirine (33A) in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML).” ANNALS OF HEMATOLOGY, vol. 96, SPRINGER, 2017, pp. S69–S69.
Walter R, Erba H, Ravandi F. A Phase 1b Study of Vadastuximab Talirine (33A) in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML). ANNALS OF HEMATOLOGY. SPRINGER; 2017. p. S69–S69.
Published In
ANNALS OF HEMATOLOGY
EISSN
1432-0584
ISSN
0939-5555
Publication Date
February 1, 2017
Volume
96
Start / End Page
S69 / S69
Publisher
SPRINGER
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology